Novo Nordisk lowers the price of Ozempic and Wegovy
Digest more
10don MSN
Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk
Pfizer has signed a deal to purchase Metsera Inc., an obesity drugmaker in the development stage, after winning a bidding war ...
The boardroom shake-up, which erupted when Novo's board Chair Helge Lund and the independent members stepped down last month ...
Novo Nordisk and Eli Lilly cut U.S. GLP-1 weight-loss drug prices, aiming for higher volumes despite near-term sales impact.
10don MSN
Pfizer adquiere Metsea, desarrolladora de fármacos contra la obesidad, tras puja con Novo Nordisk
El gigante farmacéutico estadounidense Pfizer firmó un acuerdo para adquirir Metsera Inc., la empresa desarrolladora de ...
Novo Nordisk said on Monday it would lower the U.S. price of its injectable Wegovy obesity drug and pledged to go "all in" on ...
() -Novo Nordisk has partnered with India's Emcure Pharmaceuticals to exclusively distribute and market weight-loss ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback